Personalization Page

Dallas Clinical Research Unit: Sponsor overview

David M. Cohan, MD, FACS

Dr. David Cohan, MD, FACS, Vice President, Therapeutic Strategy Leader for Oncology/Hematology at Fortrea Inc.

The EU Joint Clinical Assessment: Turning HTA reform into a market access advantage

What does the EU Joint Clinical Assessment mean for your market access strategy?

Ocular Cell and Gene Therapies

Inherited Retinal Disorders and Rare Ocular Disease

Connecting Data, People, and Patients: How AI is Advancing Neuroscience Clinical Trials

Anterior Indications

Jason Knoblauch

Jason Knoblauch joined Fortrea in July 2026 as Chief Financial Officer. He leads Fortrea’s finance strategy and organization, serving as a member of its executive team.

Posterior Indications